Skip to main content
OpenTrials
Completed

NCT Number: NCT05638178

The Corona Study of Middle Norway

CUT COVID is a cohort study establised to collect information on patients hospitalized because or with infection by SARS-CoV-2. The cohort data includes clinical data and biological samples from multiple timepoints during hospitalization, as well as data from a followup consultation 3 months after discharge.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

St. Olavs Hospital, Trondheim, MN, Norway

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Positive SARS CoV-2 infection

Exclusion criteria

-

Treatment and study plan

No intervention

Other

No intervention, cohort study.

Primary outcomes

  1. Predictors of COVID-19 severity

    Time frame: 1 year after inclusion.

    Primary aim is to assess predictors of severe COVID disease in children and adults

Sponsors and collaborators

Lead sponsor

St. Olavs Hospital

Other

Collaborators

  • Alesund Hospital
  • Helse Nord-Trøndelag HF
  • Molde Hospital
  • Namsos Hospital
  • The Research Council of Norway

Registry information

Official study title

The Middle Norway Corona Study - Individual and Genetic Risk Factors for COVID-19 Infection.

Acronym: CUT COVID-19

Important dates

Study start
2020
Primary completion
2021
Study completion
2022
First posted
Dec 6, 2022
Registry last updated
Dec 6, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.